RAINBO Research Consortium

Official account of the RAINBO program of 4 clinical trials for women with endometrial cancer. Email: [email protected]

[RAINBO Research Consortium @RAINBOprogram]

The RAINBO program is a platform of 4 international clinical trials on novel personalised therapies for women with endometrial cancer. Details on its design and current status are available at:
https://t.co/HYHWqoY1Nc
#CancerResearch #wombcancer #clinicaltrials

[RAINBO Research Consortium @RAINBOprogram]

Another 🌈 RAINBO trial has opened for accrual! The 🍅 p53abn-RED trial has included its 1st patient in France. In this trial, led by dr. Leary, the benefit of the addition of a PARP-i to chemoradiation is investigated in women with invasive stage I-III p53abn endometrial cancer

[RAINBO Research Consortium @RAINBOprogram]

https://t.co/cV87ChBbIU

The podcast on the design of the RAINBO program and the RED, GREEN, ORANGE and BLUE trials with prof. Creutzberg, dr. Leary and dr. Horeweg is now available on Spotify

[Nanda Horeweg @NandaHoreweg]

Happy to be invited by the NVSO to give a Masterclass today on endometrial cancer for Dutch nurse practitioners specialised in gynaecology and oncology in this first #UterineCancer Awareness Month. From translational research to new treatments: the @RAINBOprogram

[RAINBO Research Consortium @RAINBOprogram]

Junior principal investigator @Merve_Kaya___ presents the design of the 🌈RAINBO MMRd-GREEN trial at #ASCO23
A phase III trial investigating the addition of durvalumab to pelvic RT in women with stage IB/II (with substantial LSVI) and stage III MMRd endometrial cancer

[RAINBO Research Consortium @RAINBOprogram]

@FBMH_SR @helenwhite100 @FBMH_UoM @peachestrust Congratulations @helenwhite100 Your outstanding work has given women with womb cancer a voice and created a bridge with scientists. We are proud and happy to have you in our Advisory Committee.

[RAINBO Research Consortium @RAINBOprogram]

@AndreFernandes2 @NandaHoreweg @DrMelaniePowell @ProfEmmaCrosbie Unfortunately we could not all join the podcast. But we are grateful to @pedroramirezMD @IJGConline to have had the opportunity to increase awareness on our trials that aim to reduce risk of recurrence and toxicity and improve quality of life in women with endometrial cancer

[RAINBO Research Consortium @RAINBOprogram]

@AndreFernandes2 @NandaHoreweg The RAINBO Core Group consists of Carien Creutzberg (Chair) Alexandra Leary (PI RED), Judith Kroep (PI GREEN), @DrMelaniePowell & @ProfEmmaCrosbie (PIs ORANGE), Kathy Han & Jessica McAlpine (PIs BLUE), Nanda Horeweg (overarching coordinator) and Tjalling Bosse (translational lead

[Andreina Fernandes @AndreFernandes2]

A very interesting podcast about the #RAINBOtrial 🌈 congratulations to these amazing women!!👏🏽👏🏽

[Pedro T Ramirez @pedroramirezMD]

Such an outstanding team #RAINBO Consortium! #EndometrialCancer Truly a fantastic #Podcast @IJGConline @IJGCfellows @ESGO_society @IGCSociety @SGO_org @MethodistHosp

[Nanda Horeweg @NandaHoreweg]

RAINBO Consortium representatives joined @pedroramirezMD for the podcast of the International Journal of Gynecological Cancer. Listen to learn about the background, rationale and design of the @RAINBOprogram and questions by the @IJGCfellows https://t.co/OHzdmPyYjs

[RAINBO Research Consortium @RAINBOprogram]

Representatives of the RAINBO Consortium joined @pedroramirezMD for the podcast of @IJGConline to discuss our 4 clinical trials and answering interesting questions from the @IJGCfellows Thank you for this opportunity and looking forward to the release of the recording. ❤️💚🧡💙

[IJGC @IJGConline]

#2023SpecialIssue
Update in the #MolecularClassification of #EndometrialCarcinoma 🧬

🔗 https://t.co/d1oPSTRNRT

@AliciaLenCasti1 @pedroramirezMD @HsuMd @agz_eriksson @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows @GynMe4

[Nanda Horeweg @NandaHoreweg]

Great way to stay up to date.
Thank you for including the 🌈@RAINBOprogram trial paper in this episode (4:55). Tune in to hear about the design of the 🍓p53abn-RED, 🥝MMRd-GREEN, 🍊NSMP-ORANGE, and 🫐POLEmut-BLUE trials.

[RAINBO Research Consortium @RAINBOprogram]

The TransPORTEC study that informed the design of the NSMP-ORANGE trial for women with high-risk NSMP endometrial cancer is out.
Read the paper by Lisa Vermij et al. in Br J Cancer. https://t.co/P0dMjwaXi3 @ProfEmmaCrosbie

[RAINBO Research Consortium @RAINBOprogram]

@IJGConline @IJGCfellows @BonaldoGiulio @nagustiga @DrJenOG @RyanKahnMD1 @gvantsagk @nissiemburu @ProfEmmaCrosbie @NoutRemi @remi_nout @fblancdurand @DrPrachiMittal @ViktorKoelzer @IID_learning @sarahfremond @helenwhite100 @frafanfani @DrMelaniePowell @supriyasastri @angelica_onco @lisavermij

[IJGC @IJGConline]

#ClinicalTrial Refining adjuvant treatment in #endometrialcancer based on molecular features: the #RAINBO clinical trial program 🌈 #MolecularClassification @RAINBOprogram
👉 https://t.co/pF7WmVj1c2
@pedroramirezMD @agz_eriksson @HsuMd @JayrajAarthi @AndreFernandes2

[RAINBO Research Consortium @RAINBOprogram]

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program https://t.co/JuelUxQ6xA

[Emma Davidson @ProfEmmaCrosbie]

Proud to co-lead the @RAINBOprogram ORANGE trial with @DrMelaniePowell on behalf of an incredible international consortium with Carien Creutzberg, Tjalling Bosse, Judith Kroep, Alexandra Leary, Jessica McAlpine, Kathy Han, Nanda Horeweg & Team
https://t.co/Y99bO51q89

[Andreina Fernandes @AndreFernandes2]

The #RAINBOprogram 🌈 will allow us to demonstrate the benefits of the molecular classification of #endometrialcancer over adjuvant treatment. 🫶🏽🧬🫶🏽

[RAINBO Research Consortium @RAINBOprogram]

Our paper describing the design of the RAINBO program is published! Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO program of 4 clinical trials https://t.co/JuelUxQ6xA
Thank you to @IJGConline @pedroramirezMD @Frumovitz